{"id":23605,"date":"2000-03-17T12:51:17","date_gmt":"2000-03-17T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23605"},"modified":"2018-04-14T01:59:04","modified_gmt":"2018-04-14T06:59:04","slug":"23605","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23605\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 17 de mar\u00e7o de 2000"},"content":{"rendered":"

****************************************************************
\nBrakke Consulting’s
\nAnimal Health News & Notes for March 17, 2000
\n<\/strong>Copyright © Brakke Consulting, Inc.
\n****************************************************************
\nCompany Earnings Releases
\n\uf0fc Bayer AG reported sales of its animal health group were 917 million euros ($920 million), up 3.5% over the prior year’s revenues of 886 million euros.  Growth was attributed to the companion animal sector, which was reported to represent almost half of the animal health group’s sales. (Bayer annual report)
\n\uf0fc Synbiotics Corp. reported results for the year ended Dec. 31, 1999.  Revenue for the year ended Dec. 31, 1999 was $32.0 million, compared with revenue of $31.7 million for the prior year.  Net loss for the year was ($749,000), compared with a net loss of ($1,911,000) for the prior year.  Direct sales in the U.S. continue grew by 40% in the fourth quarter as a result of an expanding sales force, telesales team, and industry leadership on the Internet.  (BW HealthWire)<\/p>\n

****************************************************************
\nCompany News Releases
\n\uf0fc Heska Corporation announced that it has received USDA approval to manufacture and market its new canine heartworm diagnostic product, Solo Step CH Batch Test Strips.  The Company plans to make the product available to veterinarians in approximately two weeks. (PRNewswire)
\n\uf0fc Monsanto Co. and Pharmacia & Upjohn Inc. expect to close their proposed $27 billion merger ahead of schedule. In a joint press release Wednesday, the two companies said, pending shareholder approval, they expect to close the merger on or before April 1. Monsanto and Pharmacia & Upjohn confirmed that the European Union extended the deadline for clearing the proposed merger to March 30 from March 17, based on remedies the companies offered to address regarding E.U. antitrust concerns. The companies said as part of its agreement with the E.U., they will divest a few minor pharmaceutical products in Scandinavia, which they termed immaterial to the transaction as a whole. (Dow Jones)
\n\uf0fc PetQuarters.com announced that the Company has resolved all outstanding comments with the Securities and Exchange Commission concerning its filing on Form 10-SB.  This enables the Company to comply with Nasdaq Rule 6530 and to continue trading on the over-the-counter bulletin board.  It was erroneously reported earlier that PetQuarters would be removed from trading on the OTC Bulletin Board. (PRNewswire)
\n\uf0fc Petopia.com announced that it has filed a registration statement with the Securities and Exchange Commission for an initial public offering of shares of its common stock.      CIBC World Markets will act as the lead manager of the offering. The co-managing underwriters of the offering are SG Cowen and Wit SoundView. (Business Wire)
\n\uf0fc Petstore.com has opened the Three Dog Bakery boutique at Petstore.com.  The co-branded specialty shop will include Three Dog Bakery’s distinctive all-natural food, dog treats and Gift Boxers.  (Business Wire)<\/p>\n

****************************************************************
\nAnimal Health News
\n\uf0fc PPL Therapeutics is pleased to announce that on 5th March 2000, five piglets, all healthy, were born as a result of nuclear transfer (cloning) using adult cells. This is the first time cloned pigs have been successfully produced from adult cells. The successful cloning of these pigs is a major step in achieving PPL’s xenograft objectives.  It opens the door to making modified pigs whose organs and cells can be successfully transplanted into humans.  Pigs are the preferred species for xenotransplantation on scientific and ethical grounds. Clinical trials could start in as little as four years and analysts believe the market could be worth $6 billion for solid organs alone, with as much again possible from cellular therapies, e.g. transplantable cells that produce insulin for treatment of diabetes. (PRNewswire)
\n\uf0fc Bio-Enhancement Systems Corporation (“BESCORP”) announced the successful launch of its first commercial product, the Animal Behavior Modifier (“ABM”), targeted at the beef and dairy cattle food production industries.  The ABM is a device engineered to naturally enhance the weight gain of beef cattle and the milk production of dairy cattle without the use of steroids or growth hormones.  The technology developed by the company is based on a well-established scientific principle that the application of mild, non-painful pressure to the tail of an animal will result in enhanced eating and other motivated behaviors leading to increased efficiencies in food animal products. (PRNewswire)
\n\uf0fc U.S. beef consumption rose 2% in 1999, to 66.2 pounds per person, according to the USDA, as the meat enjoyed its best year since the 1980s. Factoring in higher prices, consumer spending on beef shot up 5% to $49.2 billion, according to Chicago-based marketing firm Technomic Inc. Still, marketing research shows chicken will surpass beef as Americans’ meat of choice by 2005. (AP)
\n\uf0fc Meatpackers will soon be required to disclose the prices they are paying for livestock, under rules proposed Tuesday by the USDA. The new program, which was authorized last year by Congress, is intended to give cattle, hog and sheep producers more leverage in bargaining with processors. The pricing data are to be reported to USDA at certain times of the day. In addition to livestock, purchases of imported lamb cuts also will be covered by the reporting requirement. The department is seeking input from producers and processors on how to report the data back to the industry. USDA officials say they expect to have the system operational by this summer. (AP)
\n\uf0fc Corn that results in “cleaner” manure when fed to hogs and poultry is starting to become available to crop and livestock producers. The corn is low in phytate, the main phosphorus storage unit in corn grain. Non-ruminant animals such as poultry and hogs can’t absorb phosphorus in this form, so it passes through into the manure.  But hogs and poultry need phosphorus, so supplemental P is added to their diets. This results in manure that contains a relatively high concentration of P.  Phosphorus is a pollutant when it gets into lakes and streams. It can be washed into lakes and streams when water flows across land having phosphorus fertilizer or manure on the surface. (AnimalNet)
\n\uf0fc Purdue University researchers have developed a cost-effective, nutritional diet for pigs that produces manure with less nitrogen and less odor than typical pig excrement.  The diet has reduced crude protein in comparison to standard hog diets, and is supplemented with synthetic amino acids and cellulose.  The diet also costs less per ton than the standard hog diet. (Ascribe News)<\/p>\n

****************************************************************
\nAgribusiness News
\n\uf0fc The European Union will keep its de facto moratorium on the approval of genetically modified crops in place at least for a further six months. An EU committee had been due to decide on March 9 whether to approve marketing and sale of three new genetically modified crops in the 15-nation bloc but instead postponed a decision until the summer. EU environment ministers agreed on a de facto moratorium on new GM product approvals last June pending a new EU directive which will tighten up approval criteria. (Reuters)
\n\uf0fc A unit of life sciences group Aventis has filed suit against Monsanto, alleging that Monsanto has used its patents covering genetically modified cotton to stymie competition, the plaintiff said on Monday. The suit alleges that Monsanto has exploited its patents to exclude competition in genetically modified, or transgenic, cotton. About 65 percent of the cotton seed sold in the United States is genetically modified. Monsanto said the company will vigorously defend the suit, which it said was without merit since the patent was properly awarded. (Reuters)<\/p>\n

****************************************************************
\nBrakke Consulting Viewpoint<\/p>\n

Some interesting new  technology reported this week.  These are not the type of research projects most animal health companies feel comfortable with in their portfolios. However, one or more of these new approaches may well be successful commercially and have a positive impact on the industry.  We think it is great to have creative thinking in both academia and industry circles.  The ones reported this week address food safety, environmental, and increased productivity issues.   These are all “hot areas” for animal protein production.<\/p>\n

Have a good St. Patrick’s Day.
\n 
\n [Ron Brakke]
\n 
\n****************************************************************
\nBrakke Consulting’s Executive Search Positions<\/p>\n

We are seeking experienced, qualified, senior animal health executives.  Brakke
\nConsulting, Inc. currently has 12 executive searches for positions with various
\nclient companies.  Four of these positions are new this week.  Go to the BCI
\nweb site for further information:  https:\/\/brakkeconsulting.com<\/a><\/p>\n

****************************************************************<\/p>\n

This electronic newsletter is the sole property of Brakke Consulting, Inc.
\nAny use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.<\/p>\n

For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com<\/a>.<\/p>\n

If this email was forwarded to you and you would like to be added to the circulation list, please send an email to info@brakkeconsulting.com<\/a> (mailto:info@brakkeconsulting.com<\/a>) with “add” typed in the subject line, and your name and company affiliation in the body of the message, and you will be added to the mailing list.  If you would like for us to remove your name from the circulation list, please send an email to info@brakkeconsulting.com<\/a> (mailto:info@brakkeconsulting.com<\/a>) with “remove” and your name typed in the subject line.<\/p>\n","protected":false},"excerpt":{"rendered":"

**************************************************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting de 17 de mar\u00e7o de 2000 Copyright \u00a9 Brakke Consulting, Inc. **************************************************************** Comunicados de lucros da empresa \uf0fc A Bayer AG relatou que as vendas de seu grupo de sa\u00fade animal foram de 917 milh\u00f5es de euros ($920 milh\u00f5es), um aumento de 3,5% em rela\u00e7\u00e3o \u00e0s receitas do ano anterior de 886 milh\u00f5es de euros. O crescimento foi atribu\u00eddo ao setor de animais de companhia, que foi relatado como representando quase metade das vendas do grupo de sa\u00fade animal. (Relat\u00f3rio anual da Bayer) \uf0fc A Synbiotics Corp. relatou os resultados para o ano encerrado em 31 de dezembro de 1999. A receita para o ano encerrado em 31 de dezembro de 1999 foi de $32,0 milh\u00f5es, em compara\u00e7\u00e3o com a receita de $31,7 milh\u00f5es para o ano anterior. O preju\u00edzo l\u00edquido do ano foi de ($749.000), em compara\u00e7\u00e3o com o preju\u00edzo l\u00edquido de ($1.911.000) no ano anterior. As vendas diretas nos EUA continuaram crescendo em 40% no quarto trimestre, como resultado da expans\u00e3o da for\u00e7a de vendas, da equipe de televendas e da lideran\u00e7a do setor na Internet. (BW HealthWire) **************************************************************** Comunicados \u00e0 imprensa da empresa \uf0fc A Heska Corporation anunciou que recebeu a aprova\u00e7\u00e3o do USDA para fabricar e comercializar seu novo produto de diagn\u00f3stico para dirofilariose canina, as tiras de teste Solo Step CH Batch. A empresa planeja disponibilizar o produto aos veterin\u00e1rios em aproximadamente duas semanas. (PRNewswire) \uf0fc A Monsanto Co. e a Pharmacia & Upjohn Inc. esperam concluir sua proposta de fus\u00e3o de $27 bilh\u00f5es antes do previsto. Em um comunicado \u00e0 imprensa conjunto na quarta-feira,<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23605","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23605\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"**************************************************************** Brakke Consulting’s Animal Health News & Notes for March 17, 2000 Copyright © Brakke Consulting, Inc. **************************************************************** Company Earnings Releases \uf0fc Bayer AG reported sales of its animal health group were 917 million euros ($920 million), up 3.5% over the prior year’s revenues of 886 million euros.  Growth was attributed to the companion animal sector, which was reported to represent almost half of the animal health group’s sales. (Bayer annual report) \uf0fc Synbiotics Corp. reported results for the year ended Dec. 31, 1999.  Revenue for the year ended Dec. 31, 1999 was $32.0 million, compared with revenue of $31.7 million for the prior year.  Net loss for the year was ($749,000), compared with a net loss of ($1,911,000) for the prior year.  Direct sales in the U.S. continue grew by 40% in the fourth quarter as a result of an expanding sales force, telesales team, and industry leadership on the Internet.  (BW HealthWire) **************************************************************** Company News Releases \uf0fc Heska Corporation announced that it has received USDA approval to manufacture and market its new canine heartworm diagnostic product, Solo Step CH Batch Test Strips.  The Company plans to make the product available to veterinarians in approximately two weeks. (PRNewswire) \uf0fc Monsanto Co. and Pharmacia & Upjohn Inc. expect to close their proposed $27 billion merger ahead of schedule. In a joint press release Wednesday,View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23605\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2000-03-17T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T06:59:04+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for March 17, 2000\",\"datePublished\":\"2000-03-17T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/\"},\"wordCount\":1542,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23605\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2000-03-17T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:04+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23605\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23605\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for March 17, 2000\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23605\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"**************************************************************** Brakke Consulting’s Animal Health News & Notes for March 17, 2000 Copyright © Brakke Consulting, Inc. **************************************************************** Company Earnings Releases \uf0fc Bayer AG reported sales of its animal health group were 917 million euros ($920 million), up 3.5% over the prior year’s revenues of 886 million euros.  Growth was attributed to the companion animal sector, which was reported to represent almost half of the animal health group’s sales. (Bayer annual report) \uf0fc Synbiotics Corp. reported results for the year ended Dec. 31, 1999.  Revenue for the year ended Dec. 31, 1999 was $32.0 million, compared with revenue of $31.7 million for the prior year.  Net loss for the year was ($749,000), compared with a net loss of ($1,911,000) for the prior year.  Direct sales in the U.S. continue grew by 40% in the fourth quarter as a result of an expanding sales force, telesales team, and industry leadership on the Internet.  (BW HealthWire) **************************************************************** Company News Releases \uf0fc Heska Corporation announced that it has received USDA approval to manufacture and market its new canine heartworm diagnostic product, Solo Step CH Batch Test Strips.  The Company plans to make the product available to veterinarians in approximately two weeks. (PRNewswire) \uf0fc Monsanto Co. and Pharmacia & Upjohn Inc. expect to close their proposed $27 billion merger ahead of schedule. In a joint press release Wednesday,View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23605\/","og_site_name":"Brakke Consulting Website","article_published_time":"2000-03-17T18:51:17+00:00","article_modified_time":"2018-04-14T06:59:04+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23605\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23605\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for March 17, 2000","datePublished":"2000-03-17T18:51:17+00:00","dateModified":"2018-04-14T06:59:04+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23605\/"},"wordCount":1542,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23605\/","url":"https:\/\/brakkeconsulting.com\/23605\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2000-03-17T18:51:17+00:00","dateModified":"2018-04-14T06:59:04+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23605\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23605\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23605\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for March 17, 2000"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23605"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23605\/revisions"}],"predecessor-version":[{"id":25074,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23605\/revisions\/25074"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}